Gregory Lip

1.2k total citations
39 papers, 632 citations indexed

About

Gregory Lip is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Gregory Lip has authored 39 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 9 papers in Internal Medicine. Recurrent topics in Gregory Lip's work include Atrial Fibrillation Management and Outcomes (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Gregory Lip is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Gregory Lip collaborates with scholars based in United Kingdom, Denmark and Sweden. Gregory Lip's co-authors include Christopher J. Boos, DG Beevers, Jesper Hastrup Svendsen, Dan Dobreanu, C. Blomström‐Lundqvist, Stavros Apostolakis, Andrew Blann, N. Chung, Carina Blomström‐Lundqvist and Maria Grazia Bongiorni and has published in prestigious journals such as Circulation, European Heart Journal and Heart.

In The Last Decade

Gregory Lip

36 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Lip United Kingdom 16 508 111 97 75 42 39 632
Miklós Rohla Austria 15 419 0.8× 100 0.9× 67 0.7× 125 1.7× 34 0.8× 54 605
Jindřich Špinar Czechia 12 616 1.2× 94 0.8× 86 0.9× 141 1.9× 65 1.5× 127 834
Cemil Zencır Türkiye 16 395 0.8× 82 0.7× 91 0.9× 143 1.9× 33 0.8× 51 619
Yasuhiro Hamatani Japan 17 845 1.7× 145 1.3× 226 2.3× 85 1.1× 40 1.0× 87 973
Miriam Shteinshnaider Israel 15 250 0.5× 50 0.5× 104 1.1× 154 2.1× 25 0.6× 36 579
Yutaro Nishi Japan 9 161 0.3× 37 0.3× 64 0.7× 122 1.6× 48 1.1× 27 426
Goran Koraćević Serbia 11 217 0.4× 50 0.5× 40 0.4× 51 0.7× 24 0.6× 78 356
Yuen‐Kwun Wong Hong Kong 11 137 0.3× 43 0.4× 141 1.5× 61 0.8× 46 1.1× 22 499
G Montalescot France 11 387 0.8× 57 0.5× 36 0.4× 194 2.6× 20 0.5× 28 567
İlyas Atar Türkiye 14 460 0.9× 39 0.4× 71 0.7× 174 2.3× 21 0.5× 50 619

Countries citing papers authored by Gregory Lip

Since Specialization
Citations

This map shows the geographic impact of Gregory Lip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Lip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Lip more than expected).

Fields of papers citing papers by Gregory Lip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Lip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Lip. The network helps show where Gregory Lip may publish in the future.

Co-authorship network of co-authors of Gregory Lip

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Lip. A scholar is included among the top collaborators of Gregory Lip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Lip. Gregory Lip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lip, Gregory, et al.. (2025). Air quality and the risk of acute atrial fibrillation (EP-PARTICLES study): a nationwide study in Poland. European Journal of Preventive Cardiology. 32(18). 1852–1863. 5 indexed citations
2.
Kwok, Chun Shing, et al.. (2025). The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of randomized trials. Trends in Cardiovascular Medicine. 35(8). 517–527.
3.
Lip, Gregory, Anna Tomaszuk−Kazberuk, J. W. Kaminski, et al.. (2024). Association between exposure to air pollution and increased ischaemic stroke incidence: a retrospective population-based cohort study (EP-PARTICLES study). European Journal of Preventive Cardiology. 32(4). 276–287. 15 indexed citations
4.
5.
Guo, Yutao, Gregory Lip, & Stavros Apostolakis. (2015). Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. Current Vascular Pharmacology. 13(2). 192–201. 22 indexed citations
6.
Potpara, Tatjana, Gregory Lip, Nikolaos Dagres, et al.. (2014). Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. EP Europace. 16(2). 293–298. 28 indexed citations
7.
Hernández‐Madrid, Antonio, Jesper Hastrup Svendsen, Gregory Lip, et al.. (2013). Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. EP Europace. 15(6). 915–918. 30 indexed citations
8.
Lip, Gregory, et al.. (2013). Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. EP Europace. 15(10). 1526–1532. 13 indexed citations
9.
Shantsila, Eduard, Silvia Montoro‐García, Luke Tapp, et al.. (2012). Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways. Thrombosis and Haemostasis. 108(7). 32–40. 17 indexed citations
10.
Bongiorni, Maria Grazia, Germanas Marinskis, Gregory Lip, et al.. (2012). How European centres diagnose, treat, and prevent CIED infections: Results of an European Heart Rhythm Association survey. EP Europace. 14(11). 1666–1669. 43 indexed citations
11.
Morgan, J., et al.. (2012). Monitoring in the management of atrial fibrillation. EP Europace. 14(4). 591–592. 2 indexed citations
12.
Blann, Andrew D., Timothy Watson, Eduard Shantsila, & Gregory Lip. (2010). Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. Thrombosis and Haemostasis. 104(8). 327–334. 4 indexed citations
13.
Connolly, Derek, et al.. (2009). High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients. International Journal of Clinical Practice. 63(12). 1693–1701. 10 indexed citations
14.
Lim, Hoong Sern, Gregory Lip, & Hung‐Fat Tse. (2008). Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule. EP Europace. 10(5). 536–539. 4 indexed citations
15.
16.
Jaumdally, Rumi, C. Varma, Robert J. MacFadyen, & Gregory Lip. (2007). Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?. European Heart Journal. 28(8). 929–940. 19 indexed citations
17.
Blann, Andrew, et al.. (2005). Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. Thrombosis and Haemostasis. 94(11). 1077–1083. 28 indexed citations
18.
Lip, Gregory, Eiry Edmunds, & DG Beevers. (2001). Should patients with hypertension receive antithrombotic therapy?. Journal of Internal Medicine. 249(3). 205–214. 21 indexed citations
19.
Lip, Gregory. (2000). ABC of heart failure: Aetiology. BMJ. 320(7227). 104–107. 31 indexed citations
20.
Lip, Gregory, et al.. (1995). ABC of Atrial Fibrillation: DIFFERENTIAL DIAGNOSIS OF ATRIAL FIBRILLATION. BMJ. 311(7018). 1495–1498. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miklós Rohla Breakdown of academic impact, for papers by Jindřich Špinar Breakdown of academic impact, for papers by Cemil Zencır Breakdown of academic impact, for papers by Yasuhiro Hamatani Breakdown of academic impact, for papers by Miriam Shteinshnaider Breakdown of academic impact, for papers by Yutaro Nishi Breakdown of academic impact, for papers by Goran Koraćević Breakdown of academic impact, for papers by Yuen‐Kwun Wong Breakdown of academic impact, for papers by G Montalescot Breakdown of academic impact, for papers by İlyas Atar
Rankless by CCL
2026